Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

Read on to learn why. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the ...

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $27.00.

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...